Lack of S1PR2 in Macrophage Ameliorates Sepsis-associated Lung Injury through Inducing IL-33-mediated Type 2 Immunity
In conclusion, a lack of S1PR2 modulates type 2 immune response by upregulating IL-33 release from macrophages and alleviates sepsis-induced lung injury. Targeting S1PR2 may have a potential therapeutic value for sepsis treatment.PMID:38061028 | DOI:10.1165/rcmb.2023-0075OC (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Chenchen Gong Yue Jin Xi Wang Jiali Mao Dongdong Wang Xiangyang Yu Shiyu Chen Yang Wang Daqing Ma Xiangming Fang Kai Zhang Qiang Shu Source Type: research
A < em > NEAT < /em > Discovery Hints at Altered Golgi Signaling in Lung Fibrosis
Am J Respir Cell Mol Biol. 2023 Dec 7. doi: 10.1165/rcmb.2023-0384ED. Online ahead of print.NO ABSTRACTPMID:38060429 | DOI:10.1165/rcmb.2023-0384ED (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Claudia A Staab-Weijnitz Source Type: research
Disinherit your Descendants by Rewriting the COPD Epigenetic < em > Script < /em >
Am J Respir Cell Mol Biol. 2023 Dec 7. doi: 10.1165/rcmb.2023-0387ED. Online ahead of print.NO ABSTRACTPMID:38060824 | DOI:10.1165/rcmb.2023-0387ED (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Roc ío Fuentes-Mateos Reinoud Gosens Source Type: research
Lack of S1PR2 in Macrophage Ameliorates Sepsis-associated Lung Injury through Inducing IL-33-mediated Type 2 Immunity
In conclusion, a lack of S1PR2 modulates type 2 immune response by upregulating IL-33 release from macrophages and alleviates sepsis-induced lung injury. Targeting S1PR2 may have a potential therapeutic value for sepsis treatment.PMID:38061028 | DOI:10.1165/rcmb.2023-0075OC (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Chenchen Gong Yue Jin Xi Wang Jiali Mao Dongdong Wang Xiangyang Yu Shiyu Chen Yang Wang Daqing Ma Xiangming Fang Kai Zhang Qiang Shu Source Type: research
A < em > NEAT < /em > Discovery Hints at Altered Golgi Signaling in Lung Fibrosis
Am J Respir Cell Mol Biol. 2023 Dec 7. doi: 10.1165/rcmb.2023-0384ED. Online ahead of print.NO ABSTRACTPMID:38060429 | DOI:10.1165/rcmb.2023-0384ED (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Claudia A Staab-Weijnitz Source Type: research
Disinherit your Descendants by Rewriting the COPD Epigenetic < em > Script < /em >
Am J Respir Cell Mol Biol. 2023 Dec 7. doi: 10.1165/rcmb.2023-0387ED. Online ahead of print.NO ABSTRACTPMID:38060824 | DOI:10.1165/rcmb.2023-0387ED (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Roc ío Fuentes-Mateos Reinoud Gosens Source Type: research
Lack of S1PR2 in Macrophage Ameliorates Sepsis-associated Lung Injury through Inducing IL-33-mediated Type 2 Immunity
In conclusion, a lack of S1PR2 modulates type 2 immune response by upregulating IL-33 release from macrophages and alleviates sepsis-induced lung injury. Targeting S1PR2 may have a potential therapeutic value for sepsis treatment.PMID:38061028 | DOI:10.1165/rcmb.2023-0075OC (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Chenchen Gong Yue Jin Xi Wang Jiali Mao Dongdong Wang Xiangyang Yu Shiyu Chen Yang Wang Daqing Ma Xiangming Fang Kai Zhang Qiang Shu Source Type: research
A < em > NEAT < /em > Discovery Hints at Altered Golgi Signaling in Lung Fibrosis
Am J Respir Cell Mol Biol. 2023 Dec 7. doi: 10.1165/rcmb.2023-0384ED. Online ahead of print.NO ABSTRACTPMID:38060429 | DOI:10.1165/rcmb.2023-0384ED (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Claudia A Staab-Weijnitz Source Type: research
Disinherit your Descendants by Rewriting the COPD Epigenetic < em > Script < /em >
Am J Respir Cell Mol Biol. 2023 Dec 7. doi: 10.1165/rcmb.2023-0387ED. Online ahead of print.NO ABSTRACTPMID:38060824 | DOI:10.1165/rcmb.2023-0387ED (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Roc ío Fuentes-Mateos Reinoud Gosens Source Type: research
Lack of S1PR2 in Macrophage Ameliorates Sepsis-associated Lung Injury through Inducing IL-33-mediated Type 2 Immunity
In conclusion, a lack of S1PR2 modulates type 2 immune response by upregulating IL-33 release from macrophages and alleviates sepsis-induced lung injury. Targeting S1PR2 may have a potential therapeutic value for sepsis treatment.PMID:38061028 | DOI:10.1165/rcmb.2023-0075OC (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Chenchen Gong Yue Jin Xi Wang Jiali Mao Dongdong Wang Xiangyang Yu Shiyu Chen Yang Wang Daqing Ma Xiangming Fang Kai Zhang Qiang Shu Source Type: research
A < em > NEAT < /em > Discovery Hints at Altered Golgi Signaling in Lung Fibrosis
Am J Respir Cell Mol Biol. 2023 Dec 7. doi: 10.1165/rcmb.2023-0384ED. Online ahead of print.NO ABSTRACTPMID:38060429 | DOI:10.1165/rcmb.2023-0384ED (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Claudia A Staab-Weijnitz Source Type: research
Disinherit your Descendants by Rewriting the COPD Epigenetic < em > Script < /em >
Am J Respir Cell Mol Biol. 2023 Dec 7. doi: 10.1165/rcmb.2023-0387ED. Online ahead of print.NO ABSTRACTPMID:38060824 | DOI:10.1165/rcmb.2023-0387ED (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Roc ío Fuentes-Mateos Reinoud Gosens Source Type: research
Lack of S1PR2 in Macrophage Ameliorates Sepsis-associated Lung Injury through Inducing IL-33-mediated Type 2 Immunity
In conclusion, a lack of S1PR2 modulates type 2 immune response by upregulating IL-33 release from macrophages and alleviates sepsis-induced lung injury. Targeting S1PR2 may have a potential therapeutic value for sepsis treatment.PMID:38061028 | DOI:10.1165/rcmb.2023-0075OC (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Chenchen Gong Yue Jin Xi Wang Jiali Mao Dongdong Wang Xiangyang Yu Shiyu Chen Yang Wang Daqing Ma Xiangming Fang Kai Zhang Qiang Shu Source Type: research
A < em > NEAT < /em > Discovery Hints at Altered Golgi Signaling in Lung Fibrosis
Am J Respir Cell Mol Biol. 2023 Dec 7. doi: 10.1165/rcmb.2023-0384ED. Online ahead of print.NO ABSTRACTPMID:38060429 | DOI:10.1165/rcmb.2023-0384ED (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Claudia A Staab-Weijnitz Source Type: research
Disinherit your Descendants by Rewriting the COPD Epigenetic < em > Script < /em >
Am J Respir Cell Mol Biol. 2023 Dec 7. doi: 10.1165/rcmb.2023-0387ED. Online ahead of print.NO ABSTRACTPMID:38060824 | DOI:10.1165/rcmb.2023-0387ED (Source: Am J Respir Cell Mol...)
Source: Am J Respir Cell Mol... - December 7, 2023 Category: Respiratory Medicine Authors: Roc ío Fuentes-Mateos Reinoud Gosens Source Type: research
